btg plc (BTG:London)
Guenter R. Janhofer
Chief Medical Officer and Head of Development, BTG plc
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Dr. Guenter R. Janhofer has been Head of Development and Chief Medical Officer of BTG plc since joining in March 2009 and since 2011 Respectively. Mr. Janhofer has more than 25 years of experience in the pharmaceutical industry across all phases of clinical development from Phase I to end-stage life-cycle management and across a wide variety of therapeutic areas, including cardiovascular, metabolic, neuroscience, infectious diseases, respiratory, osteoporosis and oncology. ...
5 Fleet PlacePhone: 44 20 7575 0000
London, Greater London EC4M 7RD
Fax: 44 20 7575 0010
Board Members Memberships*There is no Board Members Memberships data available.
Technische Universität Berlin
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Fred P. Lampropoulos||Chairman, Chief Executive Officer and President|
Merit Medical Systems, Inc.
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Aijaz Tobaccowalla||Managing Director, Additional Director, Member of Board Administrative Committee and Member of Nomination & Remuneration Committee|
|Said Samih Taleb Darwazah||Chairman and Chief Executive Officer|
Hikma Pharmaceuticals plc
|John A. Amster||Co-Founder, Chief Executive Officer, President and Director|
|$700.0K||Compensation as of Fiscal Year 2013.|